Company intelligence / Profile preview

GS Futures

San Francisco, California, United Statesgsfutures.vc ↗

Ownership: Private
Development stage: Other

Overview

GS Futures is the corporate venture capital arm of South Korea’s GS Group. Founded in 2020, it invests in early-stage startups across climate & energy transition tech, construction & real estate tech, and consumer tech. It has made several investments in synthetic biology and healthcare technology companies as part of its portfolio.

Industry: Investors

Partnerships

Portfolio investments include partnerships with early-stage biotech/synthetic bio startups such as Debut Biotech and Geltor

Beyond the preview

Go deeper on GS Futures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GS Futures.

Explore the full profile